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Intestinal exposure to glucose stimu-lates the release of glucagon-likepeptide-1 (GLP-1), slows subsequent
gastric emptying, and reduces appetite.
These responses are signaled, at least in
part, by intestinal “sweet taste receptors”
(STRs), including taste receptor type 1
members 2 and 3 (T1R2, T1R3), and their
cellular signaling partners a-gustducin
and transient receptor potential cation
channel subfamily M member 5 (TRPM5)
(1). A recent study by Brown et al. (2) in
healthy humans reported that oral ingestion
of “diet soda,” containing both sucralose
(46 mg) and acesulfame potassium (AceK)
(26 mg), augmented GLP-1 release by more
than one-third after an oral glucose load
given 10 min later compared with carbon-
ated water, suggesting a potential synergy
between artiﬁcial sweeteners and glucose
in stimulating GLP-1 secretion. The design
of that study was, however, suboptimal, as
the diet soda contained a number of sub-
stances (including caramel color, gum aca-
cia, natural ﬂavors, citric acid, potassium
benzoate, phosphoric acid, and potassium
citrate) that were not controlled for. There-
fore, we evaluated whether oral adminis-
tration of sucralose and AceK in doses
comparable with those used by Brown
et al. (2) would augment the GLP-1 re-
sponse to oral glucose andmodulate gastric
emptying or glycemia in healthy humans.
Ten healthy males (mean age 33.6 6
5.9 years; BMI: 25.5 6 1.0 kg/m2) were
studied on four occasions each, separated
by $3 days, in single-blinded random-
ized fashion. Informed consent and ethics
approval were obtained. After an over-
night fast, each subject consumed either
240 mL water alone or equivalently sweet-
ened with 1) 52 mg sucralose, 2) 200 mg
AceK, or 3) 46 mg sucralose plus 26 mg
AceK (3). Ten minutes later, each drank
75 g of glucose, made up to 300 mL with
water, and containing 150 mg 13C-acetate.
Blood glucose (glucometer), plasma insulin
(ELISA), total GLP-1 (radioimmunoassay),
and gastric emptying (breath test) were
evaluated over 240 min.
Blood glucose, plasma insulin, and
total GLP-1 concentrations did not
change after either water or sweetened
drinks, prior to glucose ingestion, but
all increased after oral glucose (P, 0.001
for each), without any difference between
the 4 days (Fig. 1A–C). Neither the
13CO2:
12CO2 ratio nor the half-emptying
time (T50) differed between the 4 days
(Fig. 1D and E).
These observations differ from those
of Brown et al. (2), although the doses of
sucralose and AceK and the load and tim-
ing of the subsequent glucose drink were
identical in our study. It is unclear
whether other components of diet soda
that were not controlled for by Brown
et al. may have had the capacity to stim-
ulate GLP-1 secretion. Our ﬁndings are,
however, consistent with previous re-
ports that sucralose or AceK alone has
no effect on GLP-1 secretion, insulin, or
blood glucose concentrations (3,4) and
our observations that sucralose had no
effect on GLP-1 secretion or the glycemic
response to intraduodenal glucose in
healthy humans (5). That the STR antag-
onist, lactisole, attenuates glucose-stimulated
GLP-1 secretion suggests that activation
of STRs is necessary, but not sufﬁcient,
to stimulate L-cell secretion (1). In con-
clusion, sucralose and AceK, either alone
or in combination, have no acute effect
on gastric emptying, GLP-1, or glycemic
responses after oral glucose in healthy
humans.
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Figure 1—Effects of ingestion of either water or artiﬁcial sweeteners (sucralose, AceK, or sucralose plus AceK) (at t = 210 min) on (A) blood
glucose, (B) plasma insulin, (C) GLP-1, (D) 13CO2-to-
12CO2 ratio, and (E) T50 in response to 75-g oral glucose (at t = 0min) in healthy humans (n =
10). Data are means6 SEM. The area under the curves for blood glucose, plasma insulin, 13CO2-to-
12CO2 ratio, and T50 did not differ between the
4 study days before and after 75-g oral glucose (one-factor repeated-measures ANOVA). There was a time effect (P , 0.001) but not a treatment
effect or treatment 3 time interaction for blood glucose, plasma insulin, and 13CO2-to-
12CO2 ratio (two-factor repeated-measures ANOVA with
treatment and time as factors).
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